Leg cramps on Wegovy: what's going on and what to do about it

It starts the week your dose goes up

For a lot of people, leg cramps on Wegovy appear in a predictable pattern: within a day or two of moving to a higher dose, when nausea is at its sharpest. That timing is a useful clue. The most common underlying cause is not some direct effect of semaglutide on your muscles. It is much simpler: when nausea reduces your appetite and makes food and drink less appealing, fluid and mineral intake both drop. Muscles need a steady supply of electrolytes, particularly magnesium and potassium, and when intake falls even briefly, cramping can follow.

There is a persistent idea that the medicine itself is chemically attacking muscle. That picture is not supported by evidence, and letting go of it tends to make the problem easier to manage. The more useful frame is that your body is adjusting to a new dose, and some of that adjustment is uncomfortable.

The semaglutide medicines page has a full overview of how Wegovy works, which provides useful context for understanding why these GI-related knock-on effects happen in the first place. The NHS semaglutide medicines guide also lists muscle cramps among reported side effects, framing them as a known but infrequent occurrence worth monitoring.

The dehydration angle matters more than most people expect

Vomiting and diarrhoea, which some people experience in the early weeks or after a dose increase, compound the problem significantly. Fluid loss pulls electrolytes with it. If you are finding that cramps cluster on the same days as gut symptoms, that connection is almost certainly not a coincidence.

Practical steps that many people find helpful: sip fluids steadily through the day rather than in large gaps; include foods that are naturally rich in potassium and magnesium (bananas, leafy greens, nuts, seeds) when appetite allows; and cut back on caffeine on days when nausea is bad, since caffeine has a mild diuretic effect. None of this requires overhauling your diet; small consistent habits tend to make more difference than dramatic changes.

For an in-depth look at how Wegovy affects the body across different areas, the side effects guide covers the full picture. If stomach-related discomfort is part of what you are dealing with alongside the cramps, the page on stomach cramps on Wegovy addresses that separately.

When leg cramps need more than a glass of water

Most Wegovy leg cramps are uncomfortable rather than dangerous, and they ease as the body settles at a stable dose. But some presentations do warrant prompt attention. Contact a doctor the same day if you experience cramps accompanied by significant muscle weakness, swelling in the affected leg, or dark, tea-coloured urine. That combination can point to a condition affecting kidney function and needs clinical assessment promptly.

Similarly, if cramps are genuinely severe and are not improving after one to two weeks at a stable dose, a conversation with your prescriber is the right next step rather than pushing through. Dose timing, hydration strategies, or a temporary hold on titration are all options a clinician can discuss. Decisions about dose changes belong with your prescribing team; guidance in the Patient Information Leaflet and your prescriber's advice take precedence over general information here.

People sometimes ask whether leg cramps mean the medicine is not working or that treatment should stop. In most cases they do not indicate either. They indicate an adjustment period that is worth managing, not ending treatment over, unless your prescriber advises otherwise. For questions about how Wegovy compares in terms of its overall side-effect profile, the Wegovy overview page offers a broader context.

Cramps that appear in a different pattern — menstrual or abdominal

A small number of people taking Wegovy notice cramping that does not fit neatly into the muscle-dehydration pattern described above. Some women report changes in menstrual-related cramping during treatment; if that is your experience, the page on Wegovy and period cramps addresses what is known. Abdominal cramping that is severe and persistent, particularly if it radiates to the back, is a separate matter altogether and is described in the MHRA's safety communications as a reason to seek urgent medical help, given the known association between GLP-1 medicines and acute pancreatitis.

The MHRA Yellow Card scheme allows patients and carers to report any suspected side effect directly to the regulator. If you experience something unexpected or severe, reporting it is genuinely useful and takes only a few minutes. The broader page on cramping and semaglutide covers how different types of cramp tend to present and what distinguishes one from another. If you have further questions, the FAQs page and the contact page are both available.